Exact Mass: 432.2081
Exact Mass Matches: 432.2081
Found 30 metabolites which its exact mass value is equals to given mass value 432.2081
,
within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error
0.0002 dalton.
Mizolastine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists Mizolastine (mizollen) is a second-generation piperidine H1-antihistamine. C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Mizolastine is an orally active, high affinity and specific peripheral histamine H1 receptor antagonist (second generation antihistamine). Mizolastine effectively inhibits mRNA expression of VEGF165, VEGF120, TNF-α and KC. Mizolastine can be used in studies of allergic rhinitis and chronic idiopathic urticarial[1][2][3].
Gly Asn Arg Ser
Gly Asn Ser Arg
Gly Arg Asn Ser
Gly Arg Ser Asn
Gly Ser Asn Arg
Gly Ser Arg Asn
Asn Gly Arg Ser
Asn Gly Ser Arg
Asn Arg Gly Ser
Asn Arg Ser Gly
Asn Ser Gly Arg
Asn Ser Arg Gly
Arg Gly Asn Ser
Arg Gly Ser Asn
Arg Asn Gly Ser
Arg Asn Ser Gly
Arg Ser Gly Asn
Arg Ser Asn Gly
Ser Gly Asn Arg
Ser Gly Arg Asn
Ser Asn Gly Arg
Ser Asn Arg Gly
Ser Arg Gly Asn
Ser Arg Asn Gly
Mizolastine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Mizolastine is an orally active, high affinity and specific peripheral histamine H1 receptor antagonist (second generation antihistamine). Mizolastine effectively inhibits mRNA expression of VEGF165, VEGF120, TNF-α and KC. Mizolastine can be used in studies of allergic rhinitis and chronic idiopathic urticarial[1][2][3].
Arg-Asn-Gly-Ser
A tetrapeptide composed of L-arginine, L-asparagine, glycine, and L-serine joined in sequence by peptide linkages.